NURS 571 Final Exam
COPD is airflow limitation that is not fully reversible
t/f *** True
__________ is characterized by reversible airflow obstruction *** Asthma
1) SABA prn
2) Low dose ICS
3) Low dose ICS + LABA OR medium dose ICS
4) Medium Dose ICS + LABA
5) High dose ICS + LABA
6) High dose ICS + LABA + Oral corticosteroids
treatment for what? *** Step wise approach for asthma
Asthma:
incomplete response to TX
FEV1 or PEF 40-60%
mild to moderate s/s
where do you admit? *** Floor admission
Asthma:
FEV1 or PEF <40%,
PaC02 > 42mmhg
,severe symptoms
drowsiness, confusion
pending intubation
Pa02 <60%
poor response to tx
where do you admit? *** ICU admission
Drowsiness, paradoxical chest movement, absence of wheeze, bradycardia are signs of what in severe
asthma exacerbations? *** Respiratory arrest
Destruction and permanent enlargement of airspaces distal to terminal bronchioles characterized by
destruction of alveoli without obvious fibrosis and hyperinflation/air trapping is known as:
A. COPD
B. Asthma
C. Chronic Bronchitis
D. Emphysema *** D. Emphysema
Sputum production daily for 3 or more months for 2 or more years is characteristic of
_________________ *** Chronic Bronchitis
Pink puffers are ______________ and blue bloaters are ______________ *** Emphysema and COPD
COPD on CXR will show normal diaphragm, hyper-inflated lungs, normal heart size, and barrel chest, t/f?
*** False- flattened diaphragm, hyper-inflated lungs small heart size, and barrel chest
Smoking> 30 years
,Chronic coughing
excessive sputum production
4th and 5th decade of life
Genetic component
Are characteristics of what? *** Typical COPD patient
Stage 1: Mild
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** A
Stage 2: moderate
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** B
Stage 3: severe
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
, C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** C
Stage 4: very severe
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** D
S/s of COPD exacerbation? *** Increase cough, dyspnea, sputum production
Oxygen SPO2 90-94% or PAO2 50-60 mm Hg
Ipratropium bromide + Beta 2 agonists
Systemic corticosteroids
Antibiotics
NIPPV/chest PT
Are treatments for what? *** COPD exacerbation
COPD:
worsening cor pulmonale
unresponsive to outpatient tx
worsen pulmonary function
Patient has an acute exacerbation plus one or more of the following:
COPD is airflow limitation that is not fully reversible
t/f *** True
__________ is characterized by reversible airflow obstruction *** Asthma
1) SABA prn
2) Low dose ICS
3) Low dose ICS + LABA OR medium dose ICS
4) Medium Dose ICS + LABA
5) High dose ICS + LABA
6) High dose ICS + LABA + Oral corticosteroids
treatment for what? *** Step wise approach for asthma
Asthma:
incomplete response to TX
FEV1 or PEF 40-60%
mild to moderate s/s
where do you admit? *** Floor admission
Asthma:
FEV1 or PEF <40%,
PaC02 > 42mmhg
,severe symptoms
drowsiness, confusion
pending intubation
Pa02 <60%
poor response to tx
where do you admit? *** ICU admission
Drowsiness, paradoxical chest movement, absence of wheeze, bradycardia are signs of what in severe
asthma exacerbations? *** Respiratory arrest
Destruction and permanent enlargement of airspaces distal to terminal bronchioles characterized by
destruction of alveoli without obvious fibrosis and hyperinflation/air trapping is known as:
A. COPD
B. Asthma
C. Chronic Bronchitis
D. Emphysema *** D. Emphysema
Sputum production daily for 3 or more months for 2 or more years is characteristic of
_________________ *** Chronic Bronchitis
Pink puffers are ______________ and blue bloaters are ______________ *** Emphysema and COPD
COPD on CXR will show normal diaphragm, hyper-inflated lungs, normal heart size, and barrel chest, t/f?
*** False- flattened diaphragm, hyper-inflated lungs small heart size, and barrel chest
Smoking> 30 years
,Chronic coughing
excessive sputum production
4th and 5th decade of life
Genetic component
Are characteristics of what? *** Typical COPD patient
Stage 1: Mild
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** A
Stage 2: moderate
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** B
Stage 3: severe
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
, C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** C
Stage 4: very severe
A. FEV1/FVC <70%, FEV1> 80%
B.FEV1/FVC <70%, FEV1 50-79%
C.FEV1/FVC <70%, FEV1 30-49% with or w/o sx
D.FEV1/FVC <70%, FEV1 <30% or <50% with resp failure *** D
S/s of COPD exacerbation? *** Increase cough, dyspnea, sputum production
Oxygen SPO2 90-94% or PAO2 50-60 mm Hg
Ipratropium bromide + Beta 2 agonists
Systemic corticosteroids
Antibiotics
NIPPV/chest PT
Are treatments for what? *** COPD exacerbation
COPD:
worsening cor pulmonale
unresponsive to outpatient tx
worsen pulmonary function
Patient has an acute exacerbation plus one or more of the following:
